Drug shortage: Epinephrine Bitartrate, Lidocaine Hydrochloride Injection (XYLOCAINE MPF, XYLOCAINE)
FDA lists 22 presentations as Current. Availability: Unavailable (8), Limited Availability (5), Available (9). Reason: Other; Demand increase for the drug. Companies: Hospira, Inc., a Pfizer Company, Fresenius Kabi USA, LLC.
- Published by source
- 2012-02-22
- First seen by Reality Radar
- 2026-10-22
- Last verified
- 2026-10-22
Affected
- Manufacturer
- Hospira, Inc., a Pfizer Company
- Products
- Epinephrine Bitartrate, Lidocaine Hydrochloride Injection XYLOCAINE MPF XYLOCAINE
Whether your exact unit is affected depends on the model, serial number and region in the official notice.
What the official notice says
Risk: Current — Unavailable
Remedy / actions:
- Limited Supply Available. Next Delivery: May 2027; Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing Delay
- Next release October 2026. Check wholesalers for inventory.
Is this affecting you?
Add what you own or use and Reality Radar will tell you when official changes match it — with evidence and next steps.
Sources
- openFDA Drug Shortages Tier A · official published 2012-02-22
Evidence ledger
Every piece of evidence we store is appended to a public hash chain, so later edits are detectable. Anyone can re-verify it.
| Entry | Kind | Observed | Evidence hash | Entry hash |
|---|---|---|---|---|
| #865 | new | 2026-10-22 | 388bd60ae2bc…0fc387 | 9a3855cb024f…a9ca76 |
Chain head: #1076 8ad5adc30b9b…88ce20